Complete Genomics (GNOM)
News
| May 29 | $GNOM 5.75% bounce back in a/h - let's see how the p/m treats it. by JKMWCL |
| May 29 | $MVIS http://stks.co/41SZ In play $MVIS $GNOM $AMRN $ALSN full blog post here http://stks.co/41Sa by LincolnList |
| May 29 | $GNOM when you have a lotto you cash in and walk away…. but might buy another ticket some day by Partridge |
| May 29 | @EUROCAYMAN Thanks for the link. It was a good article. $GNOM by SomeGuy900 |
| May 29 | RT $GNOM @EUROCAYMAN C'mon Euro, we all already know that. This just in: Water is wet! Also, no shart Sherlock! by SomeGuy900 |
| May 29 | @EUROCAYMAN re; your link on $GNOM. The gist of that is they are trying to standardize these techniques and approaches.What's your point? by SomeGuy900 |
| May 29 | @EUROCAYMAN i read it...but what's that entail for $GNOM? by benjo |
| May 29 | $GNOM 2.84 a/h!!! by EUROCAYMAN |
| May 29 | @SomeGuy900 http://stks.co/41NG here you go $GNOM by EUROCAYMAN |
| May 29 | $GNOM YES!!! read this http://stks.co/41N1 by EUROCAYMAN |
| May 29 | Health Care Sector Wrap Fox Business |
| May 29 | Vertex Pharmaceuticals Incorporated, Tractor Supply Company Among Stocks Down on Abov... |
| May 29 | William Blair Downgrades Complete Genomic (GNOM) to Market Perform Street Insider |
| May 29 | Upcoming Economic Outlook - Report Highlights Genetic Technologies Limited (ADR) and ... |
| May 29 | Benzinga's Top Pre-Market Gainers Benzinga |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Complete Genomics is down 81.86% over the last year vs S&P 500 Total Return up 1.18%, Pacific Biosciences of California down 80.32%, and Repros Therapeutics up 48.31%.
- GNOM Total Returns
- ^SPXTR Total Returns
- PACB Total Returns
- RPRX Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these GNOM related companies
Pro Strategies Featuring GNOM
Did Complete Genomics make it into our Pro Portfolio Strategies?
GNOM Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other GNOM Resources
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GNOM | 2.61 | -0.39 | -13.00% | 100.26M |
| GNMK | 4.61 | +0.03 | +0.66% | 93.89M |
| GNK | 3.23 | +0.01 | +0.31% | 141.07M |
| GNI | 65.28 | +2.39 | +3.80% | 94.34M |
| GNE | 7.07 | +0.06 | +0.86% | |
| GNCMA | 6.33 | -0.36 | -5.38% | 295.30M |
| GNC | 39.54 | -0.01 | -0.03% | |
| GNAT | 21.95 | +0.36 | +1.69% | |
| GMXR | 0.95 | +0.03 | +3.26% | 62.81M |
| GMT | 38.98 | +0.31 | +0.80% | 1.811B |
